Volitionrx LTD (VNRX) financial statements (2021 and earlier)
Company profile
| Business Address |
13215 BEE CAVE PARKWAY AUSTIN, TX 78738 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 19 | 17 | 13 | 10 | 22 | 6 | 2 | ||
| Cash and cash equivalents | 19 | 17 | 13 | 10 | 22 | 6 | 2 | ||
| Receivables | 0 | ||||||||
| Prepaid expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Other current assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total current assets: | 20 | 18 | 14 | 11 | 22 | 6 | 2 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | (0) | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Operating lease, right-of-use asset | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 5 | 3 | 3 | 3 | 2 | 1 | 0 | ||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||
| Other undisclosed noncurrent assets | 0 | ||||||||
| Total noncurrent assets: | 6 | 4 | 4 | 4 | 3 | 1 | 1 | ||
| TOTAL ASSETS: | 26 | 21 | 17 | 15 | 25 | 8 | 3 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 5 | 3 | 2 | 2 | 0 | 1 | 1 | ||
| Accounts payable | 2 | 1 | 1 | 0 | |||||
| Accrued liabilities | 3 | 2 | 1 | 1 | 1 | ||||
| Other undisclosed accounts payable and accrued liabilities | (1) | 1 | 1 | ||||||
| Debt | 1 | 1 | 0 | 0 | 0 | 0 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 0 | 0 | 0 | |||
| Other undisclosed current liabilities | 0 | 0 | 0 | 0 | 2 | 0 | 2 | ||
| Total current liabilities: | 6 | 4 | 2 | 2 | 2 | 1 | 3 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 3 | 3 | 2 | 1 | 0 | ||||
| Long-term debt, excluding current maturities | 3 | 2 | 2 | 1 | 0 | ||||
| Finance lease, liability | 1 | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Operating lease, liability | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed noncurrent liabilities | 0 | 0 | 1 | 1 | 1 | 1 | 0 | ||
| Total noncurrent liabilities: | 4 | 3 | 3 | 2 | 2 | 1 | 0 | ||
| Total liabilities: | 10 | 7 | 5 | 5 | 4 | 2 | 3 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 16 | 14 | 12 | 10 | 21 | 6 | 0 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 127 | 104 | 86 | 66 | 62 | 35 | 20 | ||
| Accumulated other comprehensive income (loss) | (0) | 0 | 0 | (0) | (0) | (0) | (0) | ||
| Accumulated deficit | (110) | (90) | (74) | (56) | (41) | ||||
| Other undisclosed stockholders' equity attributable to parent | (0) | (29) | (20) | ||||||
| Other undisclosed stockholders' equity | 0 | ||||||||
| Total stockholders' equity: | 16 | 14 | 12 | 10 | 21 | 6 | 0 | ||
| Other undisclosed liabilities and equity | (0) | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 26 | 21 | 17 | 15 | 25 | 8 | 3 | ||
Income statement (P&L) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 0 | 0 | 0 | 0 | ||||
| Other income | 0 | ✕ | ||||||
| Cost of revenue (Cost of Goods and Services Sold) | (1) | |||||||
| Gross profit: | (1) | 0 | 0 | 0 | ||||
| Operating expenses | (21) | (16) | (18) | (15) | (12) | (10) | (6) | |
| Other operating expense, net | (2) | |||||||
| Other undisclosed operating income (loss) | 1 | (0) | 2 | |||||
| Operating loss: | (21) | (16) | (18) | (15) | (12) | (10) | (6) | |
| Nonoperating income (expense) | 1 | (0) | (0) | |||||
| Other nonoperating income (expense) | 0 | (0) | ||||||
| Interest and debt expense | (0) | 0 | (0) | (0) | ||||
| Loss from continuing operations before income taxes: | (21) | (16) | (18) | (15) | (12) | (10) | (6) | |
| Income tax expense | (0) | |||||||
| Other undisclosed income from continuing operations | 0 | |||||||
| Loss before gain (loss) on sale of properties: | (20) | (16) | (18) | (15) | (12) | (10) | (6) | |
| Other undisclosed net loss | (0) | |||||||
| Net loss: | (20) | (16) | (18) | (15) | (12) | (10) | (6) | |
| Other undisclosed net income (loss) attributable to parent | (0) | 0 | 0 | 0 | (2) | |||
| Net loss available to common stockholders, diluted: | (20) | (16) | (18) | (15) | (12) | (10) | (8) | |
Comprehensive Income ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (20) | (16) | (18) | (15) | (12) | (10) | (6) | |
| Other comprehensive income (loss) | (21) | (16) | 0 | (0) | 0 | (0) | ||
| Comprehensive loss: | (41) | (32) | (18) | (15) | (12) | (10) | (6) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 0 | 0 | 0 | 0 | (2) | |||
| Comprehensive loss, net of tax, attributable to parent: | (41) | (32) | (18) | (15) | (12) | (10) | (8) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.